Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  European Journal of Pharmacology

• Publication date

  1998-07-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(98)00329-XPMID 9718262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.

  1996cited by this paper
• Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts.

  1996cited by this paper
• Blockade of central angiotensin II type 1 and type 2 receptors suppresses adrenalectomy-induced NaCl intake in rats.

  1996cited by this paper
• The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.

  1995cited by this paper
• Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.

  1995cited by this paper
• Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin.

  1995cited by this paper
• Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins.

  1995cited by this paper
• Central effects of irbesartan, an AT1 antagonist in rats

  1995cited by this paper
• Brain angiotensin receptor subtypes in the control of physiological and behavioral responses.

  1994cited by this paper
• Intracerebroventricular Administration of AT1 Receptor Antisense Oligonucleotides Inhibits the Behavioral Actions of Angiotensin II

  1994cited by this paper
• Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.

  1994cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

  1993cited by this paper
• Effect of nonpeptide angiotensin receptor antagonists on water intake and salt appetite in rats.

  1992cited by this paper
• Effect of Chronic Hypertension on the Blood–Brain Barrier Permeability of Libenzapril

  1992cited by this paper
• Regional expression of c-fos antigen in the basal forebrain following intraventricular infusions of angiotensin and its modulation by drinking either water or saline.

  1992cited by this paper
• Intracerebroventricular angiotensin II‐induced thirst and sodium appetite in rat are blocked by the AT1 receptor antagonist, Losartan (DuP 753), but not by the AT2 antagonist, CGP 42112B

  1992cited by this paper
• Effect of a nonpeptide angiotensin II receptor antagonist, DuP 753, on angiotensin-related water intake in rats.

  1991cited by this paper
• Access of peripherally administered DuP 753 to rat brain angiotensin II receptors

  1991cited by this paper
• Anxiolytic-like action of DuP753, a non-peptide angiotensin II receptor antagonist.

  1990cited by this paper
• Disruption of blood-brain barrier during acute hypertension in adult and aged rats.

  1990cited by this paper
• Dependence of adrenalectomy-induced sodium appetite on the action of angiotensin II in the brain of the rat.

  1990cited by this paper
• Prospectus: Thirst and Salt Appetite

  1990cited by this paper
• The Neuroendocrinology of Thirst: Afferent Signaling and Mechanisms of Central Integration

  1990cited by this paper
• CIRCUMVENTRICULAR ORGANS - NEUROENDOCRINE INTERFACES BETWEEN THE BRAIN AND THE HEMAL MILIEU

  1990cited by this paper
• Brain angiotensin: pathways and pharmacology

  1988cited by this paper
• Functions of Angiotensin in the Central Nervous System

  1987cited by this paper
• Functions of angiotensin in the central nervous system.

  1987cited by this paper
• The Physiology of Thirst and Sodium Appetite

  1986cited by this paper
• The Renin-Angiotensin-Aldosterone System and Sodium Appetite in Rats

  1986cited by this paper
• Inhibition of Ang II-Induced Drinking by Dermorphin Given into the SFO or into the Lateral Ventricle of Intact or of SFO Lesioned Rats

  1986cited by this paper
• Endogenous Angiotensin and Sodium Appetite

  1986cited by this paper
• Impaired drinking responses of rats with lesions of nucleus medianus: circadian dependence.

  1985cited by this paper
• Involvement of the renin‐angiotensin system in captopril‐induced sodium appetite in the rat.

  1984cited by this paper
• The Renin-Angiotensin-System in the Brain

  1982cited by this paper
• Central and Peripheral Mechanisms Mediating Angiotensin-lnduced Thirst

  1982cited by this paper
• Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain.

  1980cited by this paper
• The physiology of thirst and sodium appetite.

  1979cited by this paper
• Ventricular obstruction: effect on drinking induced by intracranial injection of angiotensin

  1975cited by this paper

• Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan.

  2024cites this paper
• Connecting the brain cholesterol and renin–angiotensin systems: potential role of statins and RAS‐modifying medications in dementia

  2018cites this paper
• Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?

  2017cites this paper
• Combining irbesartan and trichlormethiazide enhances blood pressure reduction via inhibition of sympathetic activity without adverse effects on metabolism in hypertensive rats with metabolic syndrome

  2015cites this paper
• Should losartan be administered following brain injury?

  2014cites this paper
• Influence of losartan intake on the circadian rhythm of melatonin secretion in humans.

  2014cites this paper
• A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists

  2013cites this paper
• PARTICIPAÇÃO DO SISTEMA RENINA-ANGIOTENSINA NA FORMAÇÃO DE ESPÉCIES REATIVAS DE OXIGÊNIO NA OVULAÇÃO DE RATAS OBESAS

  2013cites this paper
• Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment

  2013cites this paper
• Cardiac sympathoexcitation in heart failure.

  2013cites this paper
• Autonomic Neuroscience: Basic and Clinical

  2013cites this paper
• Role of angiotensin II in the brain inflammatory events during experimental diabetes in rats.

  2012cites this paper
• Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders

  2012cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012cites this paper
• AT1 Receptor Antagonism Does Not Influence Early Radiation-Induced Changes in Microglial Activation or Neurogenesis in the Normal Rat Brain

  2011cites this paper
• Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.

  2010cites this paper
• Administration of angiotensin II in the paraventricular nucleus protects gastric mucosa from ischemia-reperfusion injury.

  2008cites this paper
• Loss of vitamin D receptor produces polyuria by increasing thirst.

  2008cites this paper
• Hypophagic effect of the angiotensin AT1 receptor antagonist irbesartan in rats.

  2007cites this paper
• Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels.

  2005cites this paper
• Clinical Pharmacokinetics of Losartan

  2005cites this paper
• Brain Angiotensin II, an Important Stress Hormone: Regulatory Sites and Therapeutic Opportunities

  2004cites this paper
• Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.

  2004cites this paper
• Pharmacokinetics and the Cardiovascular Effects of Irbesartan in Aortic Coarctated Rats

  2003cites this paper
• AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.

  2003cites this paper
• Angiotensin II-induced drinking and pressor responses to central or systemic irbesartan and losartan.

  2002cites this paper
• Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats

  2002cites this paper
• Does the Angiotensin II Receptor Antagonist Losartan Improve Cognitive Function?

  2002cites this paper
• Tratamiento de la hipertensión arterial leve-moderada con tres formulaciones de irbesartán

  2002cites this paper
• Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension.

  2002cites this paper
• AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.

  2001cites this paper
• Peripheral Administration of an Angiotensin II AT1 Receptor Antagonist Decreases the Hypothalamic-Pituitary-Adrenal Response to Isolation Stress.

  2001cites this paper
• Peripheral administration of an angiotensin II AT(1) receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation Stress.

  2001cites this paper
• Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress

  2001cites this paper
• Irbesartan: an updated review of its use in cardiovascular disorders.

  2000cites this paper
• Synergistic effects of AT(1) and ET(A) receptor blockade in a transgenic, angiotensin II-dependent, rat model.

  2000cites this paper
• Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors.

  2000cites this paper
• Irbesartan

  2000cites this paper
• Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.

  1999cites this paper